Listed

Staar Surgical Co

STAANasdaqCIK 718937HealthcareFiscal year ends Jan 2

Latest reported revenue, Q2 FY2026$93.5mRevenue, Q2 FY2026, three months to 2026-07-03$93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figureThree months to Jul 3, 2026, from the 10-Q filed Aug 12, 2026.

Latest quarter: Q2 FY2026

Three months to Jul 3, 2026, against the same quarter a year earlier.

  • Revenue$93.5mRevenue, Q2 FY2026, three months to 2026-07-03$93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure+111.0% on a year earlier
  • Gross margin74.5%Gross margin, Q2 FY2026, three months to 2026-07-03. gross profit / revenueGross profit: $69.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure+0.5 pts on a year earlier
  • Operating margin10.8%Operating margin, Q2 FY2026, three months to 2026-07-03. operating income / revenueOperating income: $10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure+78.4 pts on a year earlier
  • Net margin8.6%Net margin, Q2 FY2026, three months to 2026-07-03. net income / revenueNet income: $8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure+46.5 pts on a year earlier
  • Diluted EPS$0.16Diluted EPS, Q2 FY2026, three months to 2026-07-03$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figureSign changed from a year earlier
  • Free cash flow$19.2mFree cash flow, Q2 FY2026, three months to 2026-07-03. operating cash flow − capital expenditureOperating cash flow: $19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0000718937-26-000037. Derived: 6-month figure less the 3-month figure.Capital expenditure: $494.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0000718937-26-000037. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$93.5mGross margin 74.5%
Diluted EPS$0.16, Q2 FY2026
Free cash flow$19.2m, Q2 FY2026
Staar Surgical Co, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-27Q4 FY20242024-12-27Q1 FY20252025-03-28Q2 FY20252025-06-27Q3 FY20252025-09-26Q4 FY20252026-01-02Q1 FY20262026-04-03Q2 FY20262026-07-03Shape over the periods
Revenue$m88.6Revenue, Q3 FY2024, three months to 2024-09-27$88.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure49.0Revenue, Q4 FY2024, three months to 2024-12-27$49.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure42.6Revenue, Q1 FY2025, three months to 2025-03-28$42.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure44.3Revenue, Q2 FY2025, three months to 2025-06-27$44.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure94.7Revenue, Q3 FY2025, three months to 2025-09-26$94.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure57.8Revenue, Q4 FY2025, three months to 2026-01-02$57.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure93.5Revenue, Q1 FY2026, three months to 2026-04-03$93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure93.5Revenue, Q2 FY2026, three months to 2026-07-03$93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure
Gross margin%77.3%Gross margin, Q3 FY2024, three months to 2024-09-27. gross profit / revenueGross profit: $68.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Revenue: $88.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure64.7%Gross margin, Q4 FY2024, three months to 2024-12-27. gross profit / revenueGross profit: $31.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Revenue: $49.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure65.8%Gross margin, Q1 FY2025, three months to 2025-03-28. gross profit / revenueGross profit: $28.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Revenue: $42.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure74.0%Gross margin, Q2 FY2025, three months to 2025-06-27. gross profit / revenueGross profit: $32.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $44.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure82.2%Gross margin, Q3 FY2025, three months to 2025-09-26. gross profit / revenueGross profit: $77.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Revenue: $94.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure75.7%Gross margin, Q4 FY2025, three months to 2026-01-02. gross profit / revenueGross profit: $43.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Revenue: $57.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure73.6%Gross margin, Q1 FY2026, three months to 2026-04-03. gross profit / revenueGross profit: $68.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure74.5%Gross margin, Q2 FY2026, three months to 2026-07-03. gross profit / revenueGross profit: $69.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure
Operating margin%6.4%Operating margin, Q3 FY2024, three months to 2024-09-27. operating income / revenueOperating income: $5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Revenue: $88.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure(57.0%)Operating margin, Q4 FY2024, three months to 2024-12-27. operating income / revenueOperating income: −$27.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Revenue: $49.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(134.8%)Operating margin, Q1 FY2025, three months to 2025-03-28. operating income / revenueOperating income: −$57.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Revenue: $42.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure(67.6%)Operating margin, Q2 FY2025, three months to 2025-06-27. operating income / revenueOperating income: −$30.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $44.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure19.5%Operating margin, Q3 FY2025, three months to 2025-09-26. operating income / revenueOperating income: $18.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Revenue: $94.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure(39.5%)Operating margin, Q4 FY2025, three months to 2026-01-02. operating income / revenueOperating income: −$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Revenue: $57.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure8.5%Operating margin, Q1 FY2026, three months to 2026-04-03. operating income / revenueOperating income: $8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure10.8%Operating margin, Q2 FY2026, three months to 2026-07-03. operating income / revenueOperating income: $10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure
Net margin%11.3%Net margin, Q3 FY2024, three months to 2024-09-27. net income / revenueNet income: $10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Revenue: $88.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure(69.9%)Net margin, Q4 FY2024, three months to 2024-12-27. net income / revenueNet income: −$34.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Revenue: $49.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(127.3%)Net margin, Q1 FY2025, three months to 2025-03-28. net income / revenueNet income: −$54.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Revenue: $42.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure(37.9%)Net margin, Q2 FY2025, three months to 2025-06-27. net income / revenueNet income: −$16.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $44.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure9.4%Net margin, Q3 FY2025, three months to 2025-09-26. net income / revenueNet income: $8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Revenue: $94.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figure(31.7%)Net margin, Q4 FY2025, three months to 2026-01-02. net income / revenueNet income: −$18.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Revenue: $57.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure5.6%Net margin, Q1 FY2026, three months to 2026-04-03. net income / revenueNet income: $5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure8.6%Net margin, Q2 FY2026, three months to 2026-07-03. net income / revenueNet income: $8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Revenue: $93.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure
Diluted EPS$ per share0.20Diluted EPS, Q3 FY2024, three months to 2024-09-27$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figurenot reported (Diluted EPS not reported)(1.10)Diluted EPS, Q1 FY2025, three months to 2025-03-28−$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure(0.34)Diluted EPS, Q2 FY2025, three months to 2025-06-27−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure0.18Diluted EPS, Q3 FY2025, three months to 2025-09-26$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266879.Report this figurenot reported (Diluted EPS not reported)0.10Diluted EPS, Q1 FY2026, three months to 2026-04-03$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure0.16Diluted EPS, Q2 FY2026, three months to 2026-07-03$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0000718937-26-000037.Report this figure
Free cash flow$m(2.4)Free cash flow, Q3 FY2024, three months to 2024-09-27. operating cash flow − capital expenditureOperating cash flow: $3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266879. Derived: 9-month figure less the 6-month figure.Capital expenditure: $6.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266879. Derived: 9-month figure less the 6-month figure.Report this figure(5.1)Free cash flow, Q4 FY2024, three months to 2024-12-27. operating cash flow − capital expenditureOperating cash flow: $642.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Capital expenditure: $5.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(7.2)Free cash flow, Q1 FY2025, three months to 2025-03-28. operating cash flow − capital expenditureOperating cash flow: −$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure(29.0)Free cash flow, Q2 FY2025, three months to 2025-06-27. operating cash flow − capital expenditureOperating cash flow: −$27.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0000718937-26-000037. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0000718937-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure1.8Free cash flow, Q3 FY2025, three months to 2025-09-26. operating cash flow − capital expenditureOperating cash flow: $2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266879. Derived: 9-month figure less the 6-month figure.Capital expenditure: $883.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266879. Derived: 9-month figure less the 6-month figure.Report this figure(5.6)Free cash flow, Q4 FY2025, three months to 2026-01-02. operating cash flow − capital expenditureOperating cash flow: −$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0000718937-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure(22.1)Free cash flow, Q1 FY2026, three months to 2026-04-03. operating cash flow − capital expenditureOperating cash flow: −$21.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Capital expenditure: $443.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0000718937-26-000023.Report this figure19.2Free cash flow, Q2 FY2026, three months to 2026-07-03. operating cash flow − capital expenditureOperating cash flow: $19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0000718937-26-000037. Derived: 6-month figure less the 3-month figure.Capital expenditure: $494.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0000718937-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$239.4mGross margin 76.2%
Diluted EPS−$1.62, FY2025
Free cash flow−$40.0m, FY2025
Staar Surgical Co, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-30FY20232023-12-29FY20242024-12-27FY20252026-01-02Shape over the periods
Revenue$m230Revenue, FY2021, twelve months to 2021-12-31$230.5m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-27, accession 0000950170-24-020572.Report this figure239Revenue, FY2022, twelve months to 2022-12-30$239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure322Revenue, FY2023, twelve months to 2023-12-29$322.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure314Revenue, FY2024, twelve months to 2024-12-27$313.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure239Revenue, FY2025, twelve months to 2026-01-02$239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure
Gross margin%77.5%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $178.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-27, accession 0000950170-24-020572.Revenue: $230.5m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-27, accession 0000950170-24-020572.Report this figure93.3%Gross margin, FY2022, twelve months to 2022-12-30. gross profit / revenueGross profit: $223.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-21, accession 0000950170-25-024813.Revenue: $239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure78.4%Gross margin, FY2023, twelve months to 2023-12-29. gross profit / revenueGross profit: $252.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $322.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure76.3%Gross margin, FY2024, twelve months to 2024-12-27. gross profit / revenueGross profit: $239.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $313.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure76.2%Gross margin, FY2025, twelve months to 2026-01-02. gross profit / revenueGross profit: $182.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure
Operating margin%14.5%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $33.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-27, accession 0000950170-24-020572.Revenue: $230.5m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-27, accession 0000950170-24-020572.Report this figure18.3%Operating margin, FY2022, twelve months to 2022-12-30. operating income / revenueOperating income: $43.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-21, accession 0000950170-25-024813.Revenue: $239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure8.7%Operating margin, FY2023, twelve months to 2023-12-29. operating income / revenueOperating income: $28.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $322.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(4.0%)Operating margin, FY2024, twelve months to 2024-12-27. operating income / revenueOperating income: −$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $313.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(38.3%)Operating margin, FY2025, twelve months to 2026-01-02. operating income / revenueOperating income: −$91.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure
Net margin%11.9%Net margin, FY2021, twelve months to 2021-12-30. net income / revenueNet income: $27.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2023-11-06, accession 0000950170-23-058994.Revenue: $230.5m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-27, accession 0000950170-24-020572.Report this figure16.6%Net margin, FY2022, twelve months to 2022-12-30. net income / revenueNet income: $39.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-21, accession 0000950170-25-024813.Revenue: $239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure6.6%Net margin, FY2023, twelve months to 2023-12-29. net income / revenueNet income: $21.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $322.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(6.4%)Net margin, FY2024, twelve months to 2024-12-27. net income / revenueNet income: −$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $313.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(33.6%)Net margin, FY2025, twelve months to 2026-01-02. net income / revenueNet income: −$80.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0000718937-26-000004.Revenue: $239.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure
Diluted EPS$ per share0.56Diluted EPS, FY2021, twelve months to 2021-12-30$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-11-06, accession 0000950170-23-058994.Report this figure0.80Diluted EPS, FY2022, twelve months to 2022-12-30$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-21, accession 0000950170-25-024813.Report this figure0.43Diluted EPS, FY2023, twelve months to 2023-12-29$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(0.41)Diluted EPS, FY2024, twelve months to 2024-12-27−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(1.62)Diluted EPS, FY2025, twelve months to 2026-01-02−$1.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure
Free cash flow$m30.3Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $44.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-27, accession 0000950170-24-020572.Capital expenditure: $13.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-27, accession 0000950170-24-020572.Report this figure17.6Free cash flow, FY2022, twelve months to 2022-12-30. operating cash flow − capital expenditureOperating cash flow: $35.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-21, accession 0000950170-25-024813.Capital expenditure: $18.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-21, accession 0000950170-25-024813.Report this figure(3.6)Free cash flow, FY2023, twelve months to 2023-12-29. operating cash flow − capital expenditureOperating cash flow: $14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0000718937-26-000004.Capital expenditure: $18.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(7.7)Free cash flow, FY2024, twelve months to 2024-12-27. operating cash flow − capital expenditureOperating cash flow: $15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0000718937-26-000004.Capital expenditure: $23.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure(40.1)Free cash flow, FY2025, twelve months to 2026-01-02. operating cash flow − capital expenditureOperating cash flow: −$34.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0000718937-26-000004.Capital expenditure: $5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0000718937-26-000004.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Staar Surgical Co
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BROADWOOD CAPITAL INC2026-06-30$462.6m16,123,842Unchanged
BlackRock, Inc.2026-06-30$193.1m6,731,154Added+65,036
Madison Avenue Partners, LP2026-06-30$119.8m4,175,748Added+1,734,070
Yunqi Capital Ltd2026-06-30$93.4m3,257,130Unchanged
Point72 Asset Management, L.P.2026-06-30$69.9m2,437,446Added+1,614,294
GOLDMAN SACHS GROUP INC2026-06-30$61.7m2,150,809Added+1,080,870
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$56.8m1,979,573Reduced−144,016
STATE STREET CORP2026-06-30$50.8m1,769,354Reduced−63,642
Anatole Investment Management Ltd2026-06-30$47.4m1,651,701Added+50,000
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$44.5m1,552,743Reduced−137,863

Recent filings

All 1,316 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Staar Surgical Co, recent filings
FiledFormWhat it isAccession number
2026-10-0512:25 ET8-K/A5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-413763
2026-09-1017:37 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-386662
2026-08-1216:05 ET10-QQuarterly reportPeriod 2026-07-030000718937-26-000037
2026-08-1216:04 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000718937-26-000036
2026-08-0611:04 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-337197
2026-06-2216:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000718937-26-000029
2026-06-0916:02 ET8-K5.02 Departure or appointment of officers or directors0000718937-26-000027
2026-05-1316:06 ET10-QQuarterly reportPeriod 2026-04-030000718937-26-000023
2026-05-1316:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000718937-26-000022
2026-05-0416:01 ETDEF 14AProxy statementPeriod 2026-05-010000718937-26-000015

Latest annual report

Form 10-K for the fiscal year ended Jan 2, 2026Filed Mar 3, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
718937
Tickers
STAA
Exchange
Nasdaq
SIC code
3851 Ophthalmic Goods
Sector
Healthcare
Fiscal year ends
Jan 2
Incorporated in
DE
Filer category
Large accelerated filer
Former names
STAAR SURGICAL COMPANY (to 2004-08-17)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.